Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
about
GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in menSystemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse ModelsFibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathwayKnockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisGrowth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion.MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinomaThe role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.Concise review: growth differentiation factor 15 in pathology: a clinical role?Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.Gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density.Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.Mesenchymal stem cells in tumor development: emerging roles and concepts.Targeting the bone marrow microenvironment in multiple myeloma.Early Epithelial Restitution by Nonsteroidal Anti-Inflammatory Drug-Activated Gene 1 Counteracts Intestinal Ulcerative Injuries.Myeloma and Bone Disease.GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cellsRegulation of cancer stem cell activities by tumor-associated macrophagesTranscriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myelomaTelomere length is positively associated with the expression of IL‑6 and MIP‑1α in bone marrow mesenchymal stem cells of multiple myeloma.Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease.Hepcidin and GDF15 in anemia of multiple myeloma.Serum growth differentiation factor 15 levels in newly diagnosed multiple myeloma patients.Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.Growth differentiation factor 15 in multiple myeloma: a microenvironment factor predictive of response to treatment?Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
P2860
Q28535575-A958ECB5-E081-49CE-8308-7AA68DB75B1CQ33722638-08C64844-FF72-4208-A7E1-AC23E7E46F7CQ34036138-F865E1CE-5953-41E1-9FDC-4401383339C8Q35084936-49033CD8-C919-45F8-9758-74F519549465Q35087191-15C014EB-DA9B-4B05-B9DE-C5F050FFA50AQ35475302-525745FB-7F4D-48A9-BB03-A0875CC66700Q36201496-EA17F84E-4328-4A30-97F2-7A094530D5D1Q37267749-C554194A-4714-426D-8E98-4545E64C2E1CQ37344271-6B1DEC27-EE11-45AD-B21B-AF8BB8F41DE3Q37372102-B3E303C9-D484-4AB8-8EC7-2E0D03AEF387Q37439151-D16EAF73-DD5D-4792-A56D-976C292E2243Q37535244-EB59BBA0-E810-4781-B90E-C415F164A9CAQ37724189-D0729556-615F-4A95-AB79-ACE65110A64EQ38032086-E0DD3FF7-E9B8-4613-B7E6-7662CB73CD86Q38289041-AB96BE4A-FDC7-4ABC-AFF8-F12CA281A417Q38412532-6FD89AF5-2FEF-4C8B-8972-CB0EAA90F01CQ38598342-A90A4EC8-CFEB-45F1-B2F0-99D193DF53A5Q38904689-8B177740-FEBF-4222-97A9-58A3B80C5C96Q38981228-842EF2C1-9996-440E-96BD-6EEC2E4B0F26Q39556754-EDB8B348-DCF5-42DA-ABD5-0FCD436AA22CQ42158465-4229BD52-AC61-4EEB-B3AB-0D8E0653A39CQ42378344-6E996358-0556-4D11-AAEF-208DEB494BE1Q42546876-04520A33-F042-430F-893A-0206297BB37DQ43062860-ADA377D2-B8D4-4662-A7EC-98FB0E442BB2Q44169352-168855DA-4DE7-4B9D-9B66-2546F0A2B8ADQ45840683-FEC138CC-4D24-48B0-ABDE-7FA462FB2738Q50182712-F26A979A-9796-4439-91E1-403336309CD0Q54623631-925768F1-FFC5-4125-915C-16573973A3E0Q55149583-8DC6CB91-E59C-4EF3-B8A4-D8C5333CB8D3Q55471455-5C45C7A7-B4D6-498A-ABF5-BCAD19F02E0D
P2860
Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@en
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@nl
type
label
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@en
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@nl
prefLabel
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@en
Bioactivity and prognostic sig ...... tem cells in multiple myeloma.
@nl
P2093
P50
P1433
P1476
Bioactivity and prognostic sig ...... stem cells in multiple myeloma
@en
P2093
Anne Huynh
Benjamin Hébraud
Bernard Klein
Elodie Labat
Michel Attal
Mélanie Gadelorge
P304
P356
10.1158/0008-5472.CAN-11-0188
P407
P50
P577
2012-02-02T00:00:00Z